Metagenomi Therapeutics, Inc. (MGX) EBITDA (2023 - 2026)
Metagenomi Therapeutics' EBITDA was -$27.51 million in Q2 2026, compared with -$19.65 million a year earlier.
Powered by 
Analysis
Metagenomi Therapeutics, Inc. (MGX) EBITDA (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Metagenomi Therapeutics' EBITDA was -$95.4 million through Jun 30, 2026; for FY2025, it was -$90.7 million.
- In earlier years, EBITDA was -$83.49 million in FY2024 and -$74.29 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly EBITDA since Q1 2024.
- Per Business Quant data, MGX's EBITDA in the three quarters before Q2 2026 was -$23.31 million (Q1 2026), -$23.07 million (Q4 2025) and -$21.52 million (Q3 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.51 Mn |
| Mar 31, 2026 | -23.31 Mn |
| Dec 31, 2025 | -23.07 Mn |
| Sep 30, 2025 | -21.52 Mn |
| Jun 30, 2025 | -19.65 Mn |
| Mar 31, 2025 | -26.46 Mn |
| Dec 31, 2024 | -19.16 Mn |
| Sep 30, 2024 | -21.02 Mn |
| Jun 30, 2024 | -15.55 Mn |
| Mar 31, 2024 | -27.76 Mn |
| Dec 31, 2023 | -19.00 Mn |
| Sep 30, 2023 | -21.24 Mn |
| Jun 30, 2023 | -16.95 Mn |
| Mar 31, 2023 | -17.10 Mn |
API Access
Metagenomi Therapeutics, Inc. EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();